Shigeru Tsuyuki

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Comprehensive evidence for the pathogenicity of the BRCA2 c.7847C>T (p.Ser2616Phe) variant specific to the Japanese population.

Comprehensive evidence for the pathogenicity of the BRCA2 c.7847C>T (p.Ser2616Phe) variant specific to the Japanese population.

Journal: Journal of medical genetics

Published: October 18, 2025

Trastuzumab Deruxtecan Significantly Reduces Human Epidermal Growth Factor Receptor 2-Positive Pancreatic Metastasis from Advanced Breast Cancer: A Case Report.

Trastuzumab Deruxtecan Significantly Reduces Human Epidermal Growth Factor Receptor 2-Positive Pancreatic Metastasis from Advanced Breast Cancer: A Case Report.

Journal: Surgical case reports

Published: June 09, 2025

Approaches and Challenges in the Clinical Application of On-Body Injector(G-Lasta BodyPod)

Approaches and Challenges in the Clinical Application of On-Body Injector(G-Lasta BodyPod)

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: August 27, 2024

Possibility of Prolonging Treatment by Preventing Paclitaxel-Induced Peripheral Neuropathy Using Compression Therapy

Possibility of Prolonging Treatment by Preventing Paclitaxel-Induced Peripheral Neuropathy Using Compression Therapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: November 22, 2022

Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study.

Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study.

Journal: Breast cancer (Tokyo, Japan)

Published: January 19, 2022

Evaluation of a novel medical device for pegfilgrastim administration.

Evaluation of a novel medical device for pegfilgrastim administration.

Journal: Cancer science

Published: December 14, 2021

Aortitis and aortic dissection after administration of pegfilgrastim during adjuvant chemotherapy for early breast cancer.

Aortitis and aortic dissection after administration of pegfilgrastim during adjuvant chemotherapy for early breast cancer.

Journal: International cancer conference journal

Published: April 27, 2021

Potential effectiveness of combining bevacizumab with paclitaxel for treating HER2-positive metastatic breast cancer.

Potential effectiveness of combining bevacizumab with paclitaxel for treating HER2-positive metastatic breast cancer.

Journal: International cancer conference journal

Published: April 16, 2021

Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.

Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.

Journal: Cancer science

Published: October 16, 2020

Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants.

Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants.

Journal: Communications biology

Published: March 23, 2020

Two cases of breast angiosarcoma after breast conserving surgery.

Two cases of breast angiosarcoma after breast conserving surgery.

Journal: Surgical case reports

Published: September 20, 2019

Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel as Neoadjuvant Chemotherapy in Breast Cancer Patients

Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel as Neoadjuvant Chemotherapy in Breast Cancer Patients

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: September 19, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026